| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:736384 | 6480464 | Ethinyl Estradiol results in decreased expression of GLRX mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:70951 | 6480464 | Ethinyl Estradiol results in increased expression of GLRX mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736384 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLRX mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of GLRX mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA | CTD | PMID:19684285 PMID:12377990 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736384 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GLRX mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70951 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA | CTD | PMID:18796159 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70951 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736384 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA | CTD | PMID:17035482 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736384 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLRX mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:736384 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLRX mRNA | CTD | PMID:12377990 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLRX mRNA | CTD | PMID:19684285 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:736384 | 6480464 | Glucosamine results in increased expression of GLRX mRNA | CTD | PMID:17178593 |
| 3,3',4,4'-tetrachlorobiphenyl | affects expression | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl affects the expression of GLRX mRNA | CTD | PMID:20638727 |
| 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLRX mRNA | CTD | PMID:22079614 |
| 8-hydroxy-2'-deoxyguanosine | affects abundance | EXP | | 6480464 | GLRX gene SNP affects the abundance of 8-oxo-7-hydrodeoxyguanosine | CTD | PMID:19896490 |
| aflatoxin B1 | decreases expression | ISO | RGD:736384 | 6480464 | Aflatoxin B1 results in decreased expression of GLRX mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of GLRX mRNA | CTD | PMID:22100608 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:736384 | 6480464 | Glucosamine results in increased expression of GLRX mRNA | CTD | PMID:17178593 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of GLRX mRNA | CTD | PMID:15498508 |
| ammonium chloride | affects expression | ISO | RGD:70951 | 6480464 | Ammonium Chloride affects the expression of GLRX mRNA | CTD | PMID:16483693 |
| arachidonic acid | affects response to substance | ISO | RGD:736384 | 6480464 | GLRX protein affects the susceptibility to Arachidonic Acid | CTD | PMID:19373248 |
| asbestos | affects expression | EXP | | 6480464 | Asbestos affects the expression of GLRX mRNA | CTD | PMID:17297452 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GLRX mRNA | CTD | PMID:21632981 |
| beta-D-glucosamine | increases expression | ISO | RGD:736384 | 6480464 | Glucosamine results in increased expression of GLRX mRNA | CTD | PMID:17178593 |
| cadmium atom | increases expression | ISO | RGD:70951 | 6480464 | Cadmium results in increased expression of GLRX mRNA | CTD | PMID:17327700 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride affects the activity of GLRX protein] inhibits the reaction [cinnamic aldehyde results in increased glutathionylation of RELA protein] | CTD | PMID:20351055 |
| cadmium dichloride | decreases expression | ISO | RGD:70951 | 6480464 | Cadmium Chloride results in decreased expression of GLRX protein | CTD | PMID:17976641 |
| cadmium dichloride | decreases expression | ISO | RGD:736384 | 6480464 | Cadmium Chloride results in decreased expression of GLRX protein | CTD | PMID:17976641 |
| cadmium dichloride | increases expression | ISO | RGD:70951 | 6480464 | Cadmium Chloride results in increased expression of GLRX mRNA | CTD | PMID:17327700 |
| caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of GLRX mRNA | CTD | PMID:11793227 |
| cisplatin | increases expression | ISO | RGD:736384 | 6480464 | Cisplatin results in increased expression of GLRX mRNA | CTD | PMID:21151649 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GLRX mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GLRX mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of GLRX mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GLRX mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:736384 | 6480464 | Cyclosporine results in decreased expression of GLRX mRNA | CTD | PMID:19770486 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:70951 | 6480464 | Tetrahydrocannabinol results in decreased expression of GLRX mRNA | CTD | PMID:16616335 |
| dibutyl phthalate | decreases expression | ISO | RGD:70951 | 6480464 | Dibutyl Phthalate results in decreased expression of GLRX mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:736384 | 6480464 | Diethylstilbestrol results in increased expression of GLRX mRNA | CTD | PMID:15171707 |
| diethylstilbestrol | increases expression | ISO | RGD:736384 | 6480464 | Diethylstilbestrol results in increased expression of GLRX mRNA | CTD | PMID:15171707 PMID:21041162 |
| diethylstilbestrol | increases expression | ISO | RGD:736384 | 6480464 | Diethylstilbestrol results in increased expression of GLRX mRNA | CTD | PMID:21041162 PMID:15171707 |
| dimethylarsinic acid | increases expression | ISO | RGD:70951 | 6480464 | Cacodylic Acid results in increased expression of GLRX mRNA | CTD | PMID:17720352 |
| diquat | increases response to substance | ISO | RGD:736384 | 6480464 | GLRX gene mutant form results in increased susceptibility to Diquat | CTD | PMID:17893043 |
| diuron | increases expression | ISO | RGD:70951 | 6480464 | Diuron results in increased expression of GLRX mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | GLRX protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16160061 |
| elemental selenium | increases expression | ISO | RGD:736384 | 6480464 | Selenium deficiency results in increased expression of GLRX mRNA; more ... | CTD | PMID:16170372 |
| elemental selenium | affects expression | ISO | RGD:70951 | 6480464 | Selenium affects the expression of GLRX mRNA | CTD | PMID:19351701 |
| glutathione | multiple interactions | EXP | | 6480464 | [CDC25B protein co-treated with GLRX protein co-treated with GSR protein co-treated with Glutathione] results in increased reduction of sodium arsenate; more ... | CTD | PMID:20025242 |
| glutathione | multiple interactions | ISO | RGD:70951 | 6480464 | [GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] | CTD | PMID:12680778 |
| glutathione disulfide | affects response to substance | ISO | RGD:736384 | 6480464 | GLRX protein affects the susceptibility to Glutathione Disulfide | CTD | PMID:19373248 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of GLRX mRNA | CTD | PMID:12414654 |
| indole-3-methanol | affects expression | ISO | RGD:70951 | 6480464 | indole-3-carbinol affects the expression of GLRX mRNA | CTD | PMID:21396975 |
| indole-3-methanol | multiple interactions | ISO | RGD:70951 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA | CTD | PMID:22129741 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of GLRX mRNA | CTD | PMID:12414654 |
| mercury dichloride | affects metabolic processing | EXP | | 6480464 | Mercuric Chloride affects the metabolism of GLRX protein | CTD | PMID:18321861 |
| N-acetyl-L-cysteine | affects response to substance | EXP | | 6480464 | GLRX protein affects the susceptibility to Acetylcysteine | CTD | PMID:17468103 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:70951 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA | CTD | PMID:22129741 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of GLRX mRNA | CTD | PMID:17547211 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of GLRX mRNA | CTD | PMID:17547211 |
| ozone | increases expression | ISO | RGD:70951 | 6480464 | Ozone results in increased expression of GLRX mRNA | CTD | PMID:16716893 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GLRX mRNA | CTD | PMID:11793227 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GLRX mRNA | CTD | PMID:11793227 PMID:21420995 |
| paraquat | increases response to substance | ISO | RGD:736384 | 6480464 | GLRX gene mutant form results in increased susceptibility to Paraquat | CTD | PMID:17893043 |
| paraquat | increases expression | ISO | RGD:736384 | 6480464 | Paraquat results in increased expression of GLRX mRNA | CTD | PMID:12732627 |
| phenobarbital | increases expression | ISO | RGD:736384 | 6480464 | Phenobarbital results in increased expression of GLRX mRNA | CTD | PMID:19270015 |
| phenobarbital | affects expression | ISO | RGD:736384 | 6480464 | Phenobarbital affects the expression of GLRX mRNA | CTD | PMID:23091169 |
| piperonyl butoxide | increases expression | ISO | RGD:70951 | 6480464 | Piperonyl Butoxide results in increased expression of GLRX mRNA | CTD | PMID:17498859 |
| pirinixic acid | multiple interactions | ISO | RGD:736384 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GLRX mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:736384 | 6480464 | pirinixic acid results in increased expression of GLRX mRNA | CTD | PMID:18301758 PMID:18445702 |
| pirinixic acid | increases expression | ISO | RGD:736384 | 6480464 | pirinixic acid results in increased expression of GLRX mRNA | CTD | PMID:18445702 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:736384 | 6480464 | pirinixic acid results in increased expression of GLRX mRNA | CTD | PMID:18301758 |
| propiconazole | increases expression | ISO | RGD:736384 | 6480464 | propiconazole results in increased expression of GLRX mRNA | CTD | PMID:22334560 |
| raloxifene | affects expression | EXP | | 6480464 | Raloxifene affects the expression of GLRX mRNA | CTD | PMID:14699072 |
| selenium atom | increases expression | ISO | RGD:736384 | 6480464 | Selenium deficiency results in increased expression of GLRX mRNA; more ... | CTD | PMID:16170372 |
| selenium atom | affects expression | ISO | RGD:70951 | 6480464 | Selenium affects the expression of GLRX mRNA | CTD | PMID:19351701 |
| succimer | multiple interactions | ISO | RGD:736384 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GLRX mRNA | CTD | PMID:21641980 |
| tamibarotene | increases expression | EXP | | 6480464 | Am 80 results in increased expression of GLRX mRNA; more ... | CTD | PMID:15498508 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:70951 | 6480464 | [GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] | CTD | PMID:12680778 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of GLRX mRNA | CTD | PMID:12414654 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GLRX mRNA | CTD | PMID:11793227 |
| trimellitic anhydride | increases expression | ISO | RGD:736384 | 6480464 | trimellitic anhydride results in increased expression of GLRX mRNA | CTD | PMID:19042947 |